Management of Constipation in Elderly Immobile Patients on Multiple Constipating Medications

Assessment Before Initiating Therapy

• Perform a digital rectal examination in every elderly immobile patient to rule out fecal impaction before starting any oral laxative. [Annals of Oncology 2018] 1
• If impaction is detected, manual disimpaction (digital fragmentation and extraction) must be performed first; subsequent use of a glycerin suppository or isotonic saline enema can aid clearance. [Annals of Oncology 2018] 1
• Sodium‑phosphate enemas should be avoided in this population because they carry a high risk of serious electrolyte disturbances. [Annals of Oncology 2018] 1

Initial PEG Dosing Protocol

• Start polyethylene glycol (PEG) at 17 g once daily, dissolved in 4–8 oz (≈120–240 mL) of water, juice, or another beverage; timing relative to meals is irrelevant. [Gastroenterology 2023] 2
• The therapeutic goal is one non‑forced bowel movement every 1–2 days. [JNCCN 2016] 3

Dose Escalation When Response Is Inadequate

• If no adequate response after 3–4 days, increase PEG to 17 g twice daily (total 34 g/day), each dose dissolved in ≈250 mL of water. [Annals of Oncology 2018] 1
• Add a stimulant laxative at this stage: senna 2 tablets twice daily or bisacodyl 10–15 mg 1–3 times daily. [JNCCN 2016] 3

Contraindicated Agents in This Population

• Magnesium hydroxide (Milk of Magnesia) and magnesium citrate – contraindicated because calcium‑channel blocker use and even mild renal impairment raise the risk of hypermagnesemia. [Annals of Oncology 2018; JNCCN 2016] [1][3]
• Bulk‑forming laxatives (psyllium, methylcellulose, fiber supplements) – should be avoided due to immobility and low fluid intake, which increase the risk of mechanical obstruction. [Annals of Oncology 2018; JNCCN 2016] [1][3]
• Liquid paraffin – contraindicated because of the heightened risk of aspiration lipoid pneumonia in immobile patients. [Annals of Oncology 2018] 1

Monitoring Requirements

• Closely monitor for dehydration and electrolyte imbalances when PEG is combined with calcium‑channel blockers or other osmotic agents. [Annals of Oncology 2018] 1
• Consider checking serum electrolytes every 2–4 weeks during the initial period of dose escalation. [Annals of Oncology 2018] 1

Rescue Measures When Maximum Oral Therapy Fails

• After 1 week of PEG 34 g/day plus stimulant laxatives without sufficient effect, add lactulose 30–60 mL 2–4 times daily as an additional osmotic agent. (citation not provided; omitted)
• Employ rectal interventions: bisacodyl suppository 10 mg once or twice daily or an isotonic saline enema. [Annals of Oncology 2018; JNCCN 2016] [1][3]
• For opioid‑induced constipation, consider a peripherally‑acting μ‑opioid receptor antagonist such as methylnaltrexone 0.15 mg/kg subcutaneously every other day. [JNCCN 2016] 3

Non‑Pharmacologic Support

• Ensure the patient has easy, unobstructed access to a toilet at all times. [Annals of Oncology 2018] 1
• Educate the patient (or caregiver) to attempt defecation twice daily, 30 minutes after meals, limiting straining to ≤5 minutes. [Annals of Oncology 2018] 1
• Provide dietary counseling and address reduced food intake, which can exacerbate constipation. [Annals of Oncology 2018] 1
• Increase fluid intake when not contraindicated. [Gastroenterology 2023] 2

Long‑Term Safety of PEG

• Continuous PEG use for up to 12 months in elderly patients demonstrates excellent safety and efficacy, with no clinically significant electrolyte disturbances, tachyphylaxis, or serious adverse events reported. [Gastroenterology 2023] 2
• Therapeutic response remains durable for at least 6 months without loss of effectiveness. [Gastroenterology 2023] 2
• The most common adverse effects are mild (abdominal distension, loose stools, flatulence, nausea). [Gastroenterology 2023] 2

Common Pitfall to Avoid

• Never start oral laxatives without first confirming the absence of fecal impaction; oral PEG will be ineffective and may worsen symptoms if a blockage is present. [Annals of Oncology 2018] 1

Management of Chronic Constipation in Elderly Patients

Initial Assessment and Treatment

• The American College of Physicians recommends starting with polyethylene glycol (Miralax/PEG) 17 grams once daily dissolved in 4-8 oz of water or other beverage for elderly patients with chronic constipation, which has an excellent safety profile 4, 5, 6
• A digital rectal examination is required before starting treatment to rule out fecal impaction, which would require disimpaction first before oral laxatives will be effective 7
• The goal of treatment is to achieve one non-forced bowel movement every 1-2 days 8, 7

Treatment of Fecal Impaction

• Manual disimpaction is required first, followed by glycerin suppository or isotonic saline enema (NOT phosphate enemas in elderly due to electrolyte risks) 8, 5, 6, 7
• Then, start maintenance PEG 17 grams daily to prevent recurrence 7

Dose Escalation

• If PEG 17 grams daily doesn't produce results within 3-4 days, increase to PEG 17 grams twice daily (total 34 grams/day) 8, 7
• Add bisacodyl 10-15 mg daily to three times daily as a stimulant laxative 8, 7
• Consider adding senna 2-3 tablets twice to three times daily 8

Critical Safety Considerations

• Avoid using magnesium hydroxide (Milk of Magnesia) in elderly patients, especially if any renal impairment exists, due to serious hypermagnesemia risk 4, 5, 6, 9
• Avoid bulk laxatives (psyllium, fiber) if the patient has low fluid intake or is non-ambulatory - these increase obstruction risk 4, 5, 6
• Avoid liquid paraffin if bed-bound or has swallowing difficulties due to aspiration pneumonia risk 4, 5, 6
• Monitor for dehydration and electrolyte imbalances if patient is on diuretics or cardiac glycosides 4, 5, 6

Alternative Agents

• If maximum-dose PEG (34 grams daily) plus stimulant laxatives fail after 1 week, consider lactulose 30-60 mL twice to four times daily 8, 7
• Rectal measures such as bisacodyl suppositories twice daily or isotonic saline enemas may also be used 5, 6, 7

Monitoring and Follow-up

• Reassess bowel movement frequency after 3-4 days of treatment 7
• If no improvement after 1 week of escalated therapy, re-examine for impaction or obstruction 8, 7

Non-Pharmacological Measures

• Ensure easy toilet access, especially if mobility is limited 4, 5, 6
• Encourage attempting defecation twice daily, 30 minutes after meals, straining no more than 5 minutes 4, 5, 6
• Provide dietetic support and manage decreased food intake 4, 5, 6